Targeted Cancer Therapy with Gold-Iron Oxide Nanourchins: Inducing Oxidative Stress, Paraptosis, and Sensitizing Tumor Cells to Cisplatin.
Study Goal
The researchers aimed to evaluate the anticancer potential of gold-iron oxide nanourchins (Au-Fe3O4@PEG) in various cancer cell lines and their ability to enhance the efficacy of cisplatin.
Results Summary
The study found that Au-Fe3O4@PEG nanourchins exhibited significant dose-dependent cytotoxicity in multiple cancer cell lines, induced oxidative stress, disrupted mitochondrial function, and activated autophagic and paraptotic cell death pathways in A549 lung cancer cells. Additionally, they enhanced the efficacy of cisplatin in A549 cells.
Population
Cancer cell lines (A375 melanoma, MCF7 breast, A549 lung, MIA PaCa-2 pancreatic).
Effective Dosage
Not specified.
Duration
Not specified.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | increase | cytotoxicity | A375 (melanoma), MCF7 (breast), A549 (lung), and MIA PaCa-2 (pancreatic) cancer cell lines | dose-dependent | observed significant dose-dependent cytotoxicity | #1 |
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | increase | resistance to cytotoxicity | A549 cells | highest | exhibiting the highest resistance | #2 |
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | increase | oxidative stress | A549 lung cancer cells | - | induce oxidative stress | #3 |
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | decrease | mitochondrial function | A549 lung cancer cells | - | disrupt mitochondrial function | #4 |
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | increase | autophagic and paraptotic cell death pathways | A549 lung cancer cells | - | activate autophagic and paraptotic cell death pathways | #5 |
gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs) | increase | efficacy of platinum-based chemotherapy | A549 lung cancer cells | - | enhance the efficacy of platinum-based chemotherapy, specifically cisplatin | #6 |
Nanotechnology has revolutionized cancer therapy by enabling targeted drug delivery and overcoming limitations associated with conventional chemotherapy. In this study, we explored the anticancer potential of gold-iron oxide (Au-Fe3O4@PEG) nanourchins (NUs), a class of nanoparticles with unique shape, surface features, and plasmonic properties. We tested NUs on several cancer cell lines, including A375 (melanoma), MCF7 (breast), A549 (lung), and MIA PaCa-2 (pancreatic), and observed significant dose-dependent cytotoxicity, with A549 cells exhibiting the highest resistance. Our findings also demonstrate that NUs induce oxidative stress, disrupt mitochondrial function, and activate autophagic and paraptotic cell death pathways in A549 lung cancer cells. Additionally, we explored the potential of NUs to enhance the efficacy of platinum-based chemotherapy, specifically cisplatin, in A549. The results provide valuable insights into the therapeutic potential of NUs in the context of cancer treatment, particularly for overcoming drug resistance and enhancing the effectiveness of conventional chemotherapy.